Erratum: 'Public and private pharmaceutical spending as determinants of health outcomes in Canada' (Health Economics (2004) 10.1002/hec.922);Public and private pharmaceutical spending as determinants of health outcomes in Canada

Health Economics

Volumn 14, Issue 2, 2005, Pages 107-116

  Crémieux, Pierre Yves ^a,c   Meilleur, Marie Claude ^b   Ouellette, Pierre ^c   Petit, Patrick ^b   Zelder, Martin ^a   Potvin, Ken ^d  

^a ANALYSIS GROUP   (United States)

^b GROUPE D ANALYSE   (Canada)

^c UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^d Rx/D   (Canada)

Author keywords

Canada; Drugs; Health; Infant mortality; Life expectancy

Indexed keywords

AGE; ARTICLE; CANADA; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH STATISTICS; HEALTH SURVEY; HUMAN; HYPOTHESIS; INFANT MORTALITY; LIFE EXPECTANCY; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE;

EID: 13844275827     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/hec.962     Document Type: Erratum

References (26)

1. Newhouse JP. An iconoclastic view of health cost containment. Health Affairs 1993; 12: (Suppl.): 152-171.
2. Berndt ER. The US pharmaceutical industry: why such growth in times of cost containment? Health Affairs 2001; 20: 100-114.
3. Federal /Provincial/Territorial Working Group on Drug Prices. Cost driver analysis of provincial drug plans: Ontario, 1992/93-1998/99. Federal/Provincial/Territorial Health Ministers' Meeting, 2001. http://www.pmprb-cepmb.gc.ca /PDF/studies/199-00/on-e.pdf (3 December 2002).
4. Newhouse JP. Medical-care expenditures: a cross-national survey. J Human Res 1977; 12: 115-125.
5. Leu RE. The public-private mix and international health care costs. In Public and Private Health Services, Culyer AJ. Jonsson B (eds). Basil Blackwell: Oxford, 1986; 41-63.
6. Parkin D, McGuire A, Yule B. Aggregate health care expenditures and national income - is health care a luxury good? J Health Econ 1987; 6: 109-127.
7. Hitiris T, Posnett J. The determinants and effects of health expenditure in developed countries. J Health Econ 1992; 11: 173-181.
8. Organization for Economic Co-operation and Development. OECD health data 2000: a comparative analysis of 30 countries. Paris: 2000. http://www1.oecd.org/els/health/software/ (28 August 2002).
9. Gerdtham U-G, Jönsson B. Conversion factor instability in international comparisons of health care expenditure. J Health Econ 1991; 10: 227-234.
10. Crémieux PY, Ouellette P, Pilon C. Health care spending as determinants of health outcomes. Health Econ 1999; 8: 627-639.
11. Crémieux PY, Ouellette P, Meilleur M-C, Leong S, Greenberg P, Birnbaum H. Pharmaceutical spending and health outcomes: a state level analysis. In Investing in Health: The Social and Economic Benefits of Health Care Innovation, Sorkin A, Summers K, Farquhar I (eds), vol. 14. Elsevier Science: Amsterdam, 2001; 59-76.
12. Miller RD, Frech HE III. Is there a link between pharmaceutical consumption and improved health in OECD countries? Pharmacoeconomics 2000; 18: (Suppl. 1): 33-45.
13. Régie de l'assurance-maladie du Québec. Nombre de participants, nombre de services médicaux et leur coût par participant selon le sexe, le groupe d'âge et le type de service, rémunération à l'acte, médecine et chirurgie, Québec, 2000 Québec: 2002. http://www.ramq.gouv.qc.ca/crc/sta/pdf/2000/tab213.pdf (28 August 2002).
14. Régie de l'assurance-maladie du Québec. Nombre de participants et d'ordonnances, nombre d'ordonnances par participant, coût brut des ordonnances et par participant, coût RAMQ des ordonnances et par participant selon le sexe, le groupe d'âge et la catégorie de personnes assurées, régime d'assurance médicaments, Québec, 2001. Québec: 2002. http:///www.ramq.gouv.qc.ca/crc/sta/pdf/2001/tab509.pdf (28 August 2002).
15. Newhouse JP, Phelps CE. Price and income elasticities for medical care services. In The Economics of Health and Medical Care, Perlman M (ed.). Wiley: New York, 1974; 139-161.
16. Cochrane AL, St.Leger AS, Moore F. Health service 'input' and mortality 'output' in developed countries. J Epidemiol Community Health 1978; 32: 200-205.
17. Gerdtham U-G, Søgaard J, Jönsson B, Andersson F. A pooled cross-section analysis of the health care expenditures of the OECD countries. Dev Health Econ Public Policy 1992; 1: 287-310.
18. Canadian Institute for Health Information. The evolution of public and private health care spending in Canada, 1960-1997 . Ottawa, 1999.
19. Gerdtham U-G, Søgaard J, Jönsson B, Andersson F. An econometric analysis of health care expenditure: a cross-section study of the OECD countries. J Health Econ 1992; 11: 63-84.
20. Kleiman E. The determinants of national outlay on health. In The Economics of Health and Medical Care, Perlman M (ed.). Wiley: New York, 1974; 66-81.
21. US Department of Health and Human Services. Reducing the health consequences of smoking: 25 years of progress. A Report of the Surgeon General. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Maryland, 1989.
22. US Department of Health and Human Services. The health consequences of smoking: nicotine addiction. A Report of the Surgeon General. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Health Promotion and Education, Office on Smoking and Health, Maryland, 1988.
23. Southall DP, Samuels MP. Reducing the risks in sudden infant death syndrome. Br Med J 1992; 304: 265-266.
24. Hamilton JD. Time Series Analysis. Princeton University Press: Princeton; 1994.
25. Senn S, Wilkinson RG, Sutton GC, Gravelle H. Mortality and distribution of income. Br Med J 1998; 316: 1611-1612.
26. Wolfson M, Rowe G, Gentleman J, Tomiak M. Career earnings and death: a longitudinal analysis of older Canadian men. J Gerontol 1993; 48: s167-s179.